IDEXX Laboratories, Inc.
IDXX
$528.68
-$5.24-0.98%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.08% | 10.42% | 8.39% | 6.68% | 5.56% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.08% | 10.42% | 8.39% | 6.68% | 5.56% |
| Cost of Revenue | 10.81% | 8.27% | 5.62% | 3.64% | 2.55% |
| Gross Profit | 14.52% | 11.80% | 10.18% | 8.68% | 7.55% |
| SG&A Expenses | 12.34% | 6.30% | 7.16% | 5.82% | 4.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.62% | 8.05% | 6.77% | 5.06% | 4.07% |
| Operating Income | 16.33% | 15.82% | 12.07% | 10.42% | 9.03% |
| Income Before Tax | 21.80% | 19.31% | 16.51% | 15.60% | 3.26% |
| Income Tax Expenses | 19.54% | 19.26% | 8.51% | 11.83% | 3.18% |
| Earnings from Continuing Operations | 22.38% | 19.33% | 18.61% | 16.56% | 3.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.38% | 19.33% | 18.61% | 16.56% | 3.28% |
| EBIT | 16.33% | 15.82% | 12.07% | 10.42% | 9.03% |
| EBITDA | 15.80% | 15.41% | 11.99% | 10.76% | 9.60% |
| EPS Basic | 25.40% | 22.39% | 21.44% | 18.84% | 4.66% |
| Normalized Basic EPS | 18.26% | 17.53% | 13.73% | 12.19% | 11.15% |
| EPS Diluted | 25.59% | 22.57% | 21.72% | 19.03% | 4.84% |
| Normalized Diluted EPS | 18.44% | 17.77% | 13.98% | 12.42% | 11.37% |
| Average Basic Shares Outstanding | -2.45% | -2.47% | -2.25% | -1.82% | -1.28% |
| Average Diluted Shares Outstanding | -2.60% | -2.67% | -2.46% | -2.02% | -1.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |